Il y a eu 50 transactions d'initiés récentes enregistrées pour Adamis Pharmaceuticals Corporation (ADMP), dont 7 achats et 34 ventes. Le total des achats d'initiés s'élève à $190.04K et le total des ventes d'initiés à $426.11K.
Les initiés notables ayant une activité récente comprennent Dorbin John W. Jr., Cohen Seth, Versi Ebrahim. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — ADMP
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2023-10-23 |
Dorbin John W. Jr. |
Officer |
Inconnu |
- |
- |
- |
- |
| 2023-10-23 |
Dorbin John W. Jr. |
General Counsel |
Attribution de RSU |
70,000 |
$0.58 |
$40.6K |
70,000 |
| 2023-10-16 |
Cohen Seth |
Officer |
Inconnu |
- |
- |
- |
- |
| 2023-10-16 |
Cohen Seth |
CFO |
Attribution de RSU |
151,416 |
$0.60 |
$91.09K |
151,416 |
| 2023-09-15 |
Versi Ebrahim |
CEO |
Conversion (Vente) |
729 |
- |
- |
1,212 |
| 2023-05-25 |
Desai Meera J. |
Director |
Attribution de RSU |
3,138 |
$2.50 |
$7.85K |
3,138 |
| 2023-05-25 |
Versi Jannine |
Director |
Inconnu |
- |
- |
- |
- |
| 2023-05-25 |
Versi Jannine |
Director |
Attribution de RSU |
1,941 |
- |
- |
1,941 |
| 2023-05-25 |
Versi Ebrahim |
CEO |
Inconnu |
- |
- |
- |
- |
| 2023-05-25 |
Versi Ebrahim |
CEO |
Attribution de RSU |
1,941 |
- |
- |
1,941 |
| 2022-11-14 |
Birndorf Howard C |
Director |
Restitution d'Actions |
58,824 |
- |
- |
- |
| 2022-05-25 |
Carlo Dennis J Phd |
Other: Former President & CEO |
Exercice d'Options (Vente) |
250,000 |
- |
- |
- |
| 2022-05-24 |
Reed Vickie S |
Director |
Inconnu |
- |
- |
- |
- |
| 2022-05-24 |
Reed Vickie S |
Director |
Attribution de RSU |
50,000 |
- |
- |
50,000 |
| 2022-03-18 |
Carlo Dennis J Phd |
President & CEO |
Vente Informative |
10,490 |
$0.60 |
$6.29K |
285,867 |
| 2022-03-18 |
Marguglio David J. |
SVP and Chief Business Officer |
Vente Informative |
11,859 |
$0.60 |
$7.12K |
233,906 |
| 2022-03-18 |
Moss Ronald B. |
Chief Medical Officer |
Vente Informative |
8,199 |
$0.60 |
$4.95K |
201,911 |
| 2022-03-18 |
Benedicto David C. |
Chief Financial Officer |
Vente Informative |
3,603 |
$0.61 |
$2.21K |
39,875 |
| 2021-12-31 |
Marguglio David J. |
SVP of Bus. Dev & Cbo |
Inconnu |
- |
- |
- |
5,884 |
| 2021-12-01 |
Carlo Dennis J Phd |
President & CEO |
Vente Informative |
47,870 |
$0.79 |
$37.58K |
296,357 |
| 2021-12-01 |
Marguglio David J. |
SVP and Chief Business Officer |
Vente Informative |
50,757 |
$0.79 |
$39.84K |
258,765 |
| 2021-12-01 |
Moss Ronald B. |
Chief Medical Officer |
Vente Informative |
35,553 |
$0.79 |
$27.91K |
210,110 |
| 2021-12-01 |
Benedicto David C. |
Chief Financial Officer |
Vente Informative |
13,554 |
$0.79 |
$10.64K |
43,478 |
| 2021-10-01 |
Desai Meera J. |
Director |
Inconnu |
- |
- |
- |
- |
| 2021-10-01 |
Desai Meera J. |
Director |
Attribution de RSU |
50,000 |
$1.01 |
$50.5K |
50,000 |
| 2021-05-23 |
Benedicto David C. |
Principal Accounting Officer |
Cession |
51,000 |
$3.15 |
$160.65K |
- |
| 2021-02-21 |
Carlo Dennis J Phd |
President & CEO |
Exercice d'Options (Vente) |
27,822 |
- |
- |
- |
| 2021-02-21 |
Hopkins Robert O |
Chief Financial Officer |
Exercice d'Options (Vente) |
22,258 |
- |
- |
- |
| 2021-02-21 |
Marguglio David J. |
SVP and Chief Business Officer |
Exercice d'Options (Vente) |
22,258 |
- |
- |
- |
| 2021-02-21 |
Moss Ronald B. |
Chief Medical Officer |
Exercice d'Options (Vente) |
13,911 |
- |
- |
- |
| 2020-12-31 |
Carlo Dennis J Phd |
President & CEO |
Inconnu |
- |
- |
- |
5,883 |
| 2020-12-31 |
Marguglio David J. |
SVP and Chief Business Officer |
Inconnu |
- |
- |
- |
5,884 |
| 2020-11-20 |
Hopkins Robert O |
Chief Financial Officer |
Vente Informative |
35,000 |
$0.41 |
$14.18K |
254,810 |
| 2020-11-20 |
Marguglio David J. |
SVP and Chief Business Officer |
Vente Informative |
35,000 |
$0.40 |
$14K |
287,264 |
| 2020-11-18 |
Carlo Dennis J Phd |
President & CEO |
Vente Informative |
10,665 |
$0.41 |
$4.33K |
316,405 |
| 2020-11-18 |
Hopkins Robert O |
Chief Financial Officer |
Vente Informative |
7,229 |
$0.41 |
$2.94K |
289,810 |
| 2020-11-18 |
Marguglio David J. |
SVP and Chief Business Officer |
Vente Informative |
8,532 |
$0.41 |
$3.46K |
322,264 |
| 2020-11-18 |
Daniels Karen K. |
VP of Operations |
Vente Informative |
5,333 |
$0.41 |
$2.17K |
149,242 |
| 2020-11-18 |
Moss Ronald B. |
Chief Medical Officer |
Vente Informative |
8,532 |
$0.41 |
$3.46K |
231,752 |
| 2020-09-29 |
Hopkins Robert O |
Chief Financial Officer |
Vente Informative |
20,000 |
$0.80 |
$16K |
274,781 |
| 2020-09-29 |
Marguglio David J. |
SVP and Chief Business Officer |
Vente Informative |
20,000 |
$0.80 |
$16K |
308,539 |
| 2020-08-18 |
Carlo Dennis J Phd |
President & CEO |
Vente Informative |
10,929 |
$0.87 |
$9.55K |
299,247 |
| 2020-08-18 |
Hopkins Robert O |
Chief Financial Officer |
Vente Informative |
7,418 |
$0.87 |
$6.48K |
294,781 |
| 2020-08-18 |
Marguglio David J. |
SVP and Chief Business Officer |
Vente Informative |
8,749 |
$0.87 |
$7.65K |
328,539 |
| 2020-08-18 |
Daniels Karen K. |
VP of Operations |
Vente Informative |
5,480 |
$0.87 |
$4.79K |
140,664 |
| 2020-08-18 |
Moss Ronald B. |
Chief Medical Officer |
Vente Informative |
8,749 |
$0.87 |
$7.65K |
226,373 |
| 2020-05-19 |
Daniels Karen K. |
VP of Operations |
Vente Informative |
4,855 |
$0.56 |
$2.72K |
146,144 |
| 2020-05-18 |
Carlo Dennis J Phd |
President & CEO |
Vente Informative |
9,913 |
$0.56 |
$5.55K |
310,176 |
| 2020-05-18 |
Hopkins Robert O |
Chief Financial Officer |
Vente Informative |
6,532 |
$0.56 |
$3.66K |
302,199 |
| 2020-05-18 |
Marguglio David J. |
SVP and Chief Business Officer |
Vente Informative |
7,734 |
$0.56 |
$4.33K |
337,288 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi